Transpupillary laser photocoagulation of ocular fundus: history, the present, and the future

Ardamakova, A V; Bol'shunov, A V; Il'ina, T S; Федорук, Н. А.; Siplivy, V. I.

doi:10.17116/oftalma2017133181-87

Cited by 3 publications

(1 citation statement)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Локальная гипертермия приводит к каскаду реакций с выработкой белков теплового шока, способных восстанавливать работу ПЭС. Эффективность ТТТ составляет 40-96 % по данным разных исследователей в зависимости от протоколов проводимой термотерапии, разрабатываемых и по сей день [5,[17][18][19][20][21][22].…”

Section: лечение пациентов с цсхunclassified

Current Approach to Treatment for Central Serous Chorioretinopathy. Review

Дракон¹,

Патеюк²,

Sheludchenko³

et al. 2021

Oftalʹmologiâ

View full text Add to dashboard Cite

Central serous chorioretinopathy (CSC) is a disease of complex origin and unknown etiology. Traditionally, two clinical forms of CSC are verified in accordance with the activity and duration of the pathological process: classic acute form and chronic CSC. Nowadays, there is no unified concept accepted for the management of patients with this disease, particular difficulties exist in cases of chronic CSC. This literature review highlights current trends and approaches to the treatment of CSC patients — from focal laser photocoagulation to physical methods oh therapy. The therapeutic approach as a whole depends on the form of the CHS. In most cases of the acute form of CSF, spontaneous regression, spontaneous adhesion of RPE detachment and retinal neuroepithelium are noted within several months from the onset of the disease. Therapy for the chronic form of this disease is still a difficult task and a controversial issue. Direct laser coagulation of the retina at the oozing point is recognized as the most effective method of therapy for acute typical form of CSF. In the chronic form of CSC, photodynamic therapy, transpupillary thermotherapy and subthreshold micropulse laser exposure are used. The goal of drug therapy for CSF is to activate the processes of resorption of serous fluid from the subretinal or subpigmented space, reduce the activity of pathological processes in the choroid, and improve trophism and metabolism. The currently used methods of treating chronic CSH have a number of disadvantages and variable efficacy. The existence of treatment-resistant cases is the subject of further research and clinical research. The development of new physical and physiopharmacological methods of treatment for CSF is perspective.

show abstract

Section: лечение пациентов с цсхunclassified

Current Approach to Treatment for Central Serous Chorioretinopathy. Review

Дракон¹,

Патеюк²,

Sheludchenko³

et al. 2021

Oftalʹmologiâ

View full text Add to dashboard Cite

show abstract

Episcleral circular buckling: yesterday, today, and tomorrow

Tereshchenko,

Trifanenkova,

Kulikov

et al. 2024

Rossijskij oftalʹmologičeskij žurnal

View full text Add to dashboard Cite

Searching for methods of treating primary rhegmatogenous retinal detachment (RRD) is a highly relevant issue, since this disease often leads to disability in people of young working age. The history of surgical treatment of retinal detachment began more than 200 years ago and has undergone many changes due to the evolution of knowledge of this disease. In the early 20th century, sealing of retinal breaks was first shown to be a key principle in the treatment of RRD. The two most commonly used surgical techniques today are pars plana vitrectomy and scleral buckling. Over the years, various materials have been studied as possible buckling means. At present, soft silicone fine-pored tape is the gold standard for scleral sealing. Modern laser technologies open up new vistas for extrascleral surgery in the treatment of primary RRD. The advantages of specific individual approaches or combinations thereof are under active discussion.

show abstract

A Review of Cyclodestructive Surgical Procedures for the Treatment of Various Types of Glaucoma

FURKATZOD¹,

KARIM-ZADE²,

MAKHMADZODA³

2021

View full text Add to dashboard Cite

Glaucoma remains a significant problem in ophthalmology. It is characterised by increased intraocular pressure (IOP), visual field loss, and optic nerve degeneration. Despite some progress achieved in the diagnosis and treatment of the disease, millions still suffer from glaucoma (currently, according to WHO, there are more than 106 million people globally), and many patients are already in the later stages. The accompanying pain syndrome sometimes forces doctors to remove the eye. In this regard, several so-called organ-preserving operations were introduced, the purpose of which is to reduce the production of intraocular fluid (IOF) and, accordingly, eliminate the pain syndrome. Glaucoma treatment includes conservative and surgical interventions. Surgical methods for glaucoma treatment aim to improve the outflow of intraocular fluid (fistulising operations) or reduce its production (cyclodestructive procedures). This paper analyses the evolution of surgical interventions to reduce intraocular fluid production by destroying the aqueous humour-producing ciliary processes. Systematic review searches were performed using Google Scholar, Pubmed, Web of Science, Cyberleninka, and Cochrane Library databases for articles published up to 2020 using keywords related to cyclodestruction (CD), cyclophotocoagulation (CPC), and treatment of refractory glaucoma (RG). Keywords: Glaucoma, cyclodestruction, cyclophotocoagulation, ciliary body, diode laser.

show abstract

Transpupillary laser photocoagulation of ocular fundus: history, the present, and the future

Cited by 3 publications

References 27 publications

Current Approach to Treatment for Central Serous Chorioretinopathy. Review

Current Approach to Treatment for Central Serous Chorioretinopathy. Review

Episcleral circular buckling: yesterday, today, and tomorrow

A Review of Cyclodestructive Surgical Procedures for the Treatment of Various Types of Glaucoma

Contact Info

Product

Resources

About